US4327082A
(en)
*
|
1979-07-12 |
1982-04-27 |
Adcock-Ingram Laboratories Limited |
Mastitis vaccination
|
US4425330A
(en)
|
1981-05-20 |
1984-01-10 |
Cornell Research Foundation, Inc. |
Bovine mastitis vaccine and method for detecting efficacy thereof
|
US4762712A
(en)
*
|
1983-08-31 |
1988-08-09 |
Stolle Research & Development Corporation |
Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
|
DE3345864A1
(de)
*
|
1983-12-19 |
1985-06-27 |
Egbert Frh. von 8000 München Malsen-Ponickau |
Impfstoff und verfahren zu seiner herstellung
|
FR2619122B1
(fr)
*
|
1987-08-03 |
1990-03-09 |
Pasteur Institut |
Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
|
US5034515A
(en)
*
|
1987-09-22 |
1991-07-23 |
Wisconsin Alumni Research Foundation |
Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use
|
US5055455A
(en)
*
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
US20080139789A1
(en)
*
|
1990-10-22 |
2008-06-12 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
|
US7279162B1
(en)
*
|
1990-10-22 |
2007-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
|
US5955074A
(en)
*
|
1990-10-22 |
1999-09-21 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Directed human immune globulin for the prevention and treatment of staphylococcal infections
|
US5571511A
(en)
*
|
1990-10-22 |
1996-11-05 |
The U.S. Government |
Broadly reactive opsonic antibodies that react with common staphylococcal antigens
|
ES2198405T3
(es)
*
|
1991-11-22 |
2004-02-01 |
Nabi Biopharmaceuticals |
Antigenos de superficie de tipo i asociados a staphylococcus epidermis.
|
US5980908A
(en)
*
|
1991-12-05 |
1999-11-09 |
Alfa Laval Ab |
Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
|
JPH08504167A
(ja)
*
|
1992-02-25 |
1996-05-07 |
アメリカ合衆国 |
スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン
|
US6610293B1
(en)
|
1997-06-16 |
2003-08-26 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
US7250494B2
(en)
*
|
1998-06-15 |
2007-07-31 |
Biosynexus Incorporated |
Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
|
US7252828B2
(en)
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
US6984381B2
(en)
|
2002-07-05 |
2006-01-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Vaccine for the prevention of bacterial infection of the bovine mammary gland
|
US10919956B2
(en)
|
2002-11-12 |
2021-02-16 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
US7723087B2
(en)
|
2002-11-12 |
2010-05-25 |
The Brigham And Women's Hospital, Inc. |
Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
|
PL1745075T3
(pl)
*
|
2004-04-21 |
2013-09-30 |
Brigham & Womens Hospital Inc |
Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
|
ES2472441T3
(es)
|
2004-09-22 |
2014-07-01 |
Glaxosmithkline Biologicals S.A. |
Composición inmunog�nica para uso en vacunación contra estafilococos
|
JP2009531387A
(ja)
|
2006-03-30 |
2009-09-03 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
KR20110031393A
(ko)
|
2008-07-21 |
2011-03-25 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
TW201043267A
(en)
*
|
2009-03-19 |
2010-12-16 |
Intervet Int Bv |
In situ constituting a vaccine for administration to a predetermined herd of animals
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
AU2010352695B2
(en)
|
2009-09-30 |
2014-08-21 |
Glaxosmithkline Biologicals S.A. |
Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
EP3199177A1
(en)
|
2009-10-30 |
2017-08-02 |
GlaxoSmithKline Biologicals S.A. |
Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
|
EP2655389A2
(en)
|
2010-12-24 |
2013-10-30 |
Novartis AG |
Compounds
|
CN103917245B
(zh)
|
2011-09-14 |
2017-06-06 |
葛兰素史密丝克莱恩生物有限公司 |
用于制备糖‑蛋白质糖缀合物的方法
|
CA2854934A1
(en)
|
2011-11-07 |
2013-05-16 |
Novartis Ag |
Carrier molecule comprising a spr0096 and a spr2021 antigen
|
GB201121301D0
(en)
|
2011-12-12 |
2012-01-25 |
Novartis Ag |
Method
|
MX2014014067A
(es)
|
2012-05-22 |
2015-02-04 |
Novartis Ag |
Conjugado de serogrupo x de meningococo.
|
WO2019136207A1
(en)
*
|
2018-01-05 |
2019-07-11 |
Azitra Inc |
Auxotrophic strains of staphylococcus bacterium
|